Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer-Reference-Cited by-同舟云学术

Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer

Published:2021-11-30 Issue:11 Volume:4 Page:e2136116
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Li Ning¹,Zhu Yuan²,Liu Lu-Ying²,Feng Yan-Ru²,Wang Wen-Ling³,Wang Jun⁴,Wang Hao⁵,Li Gao-Feng⁶,Tang Yuan¹,Hu Chen⁷,Liu Wen-Yang¹,Ren Hua¹,Wang Shu-Lian¹,Wang Wei-Hu⁸,Song Yong-Wen¹,Liu Yue-Ping¹,Fang Hui¹,Tang Yu¹,Lu Ning-Ning¹,Chen Bo¹,Qi Shu-Nan¹,Liu Xin-Fan¹,Li Ye-Xiong¹,Jin Jing¹

Affiliation:

1. State Key Laboratory of Molecular Oncology, Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China

2. Department of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Hangzhou, China

3. Department of Radiation Oncology, Guizhou Cancer Hospital, Guiyang, China

4. Department of Radiation Oncology, Tumor Hospital of Hebei Province, Shijiazhuang, China

5. Department of Radiation Oncology, Peking University Third Hospital, Beijing, China

6. Department of Radiation Oncology, Beijing Hospital, Beijing, China

7. Division of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland

8. Department of Radiation Oncology, Beijing Cancer Hospital, Beijing, China

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786689/li_2021_oi_211016_1637393953.8541.pdf

Reference32 articles.

1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study.;Fitzmaurice;JAMA Oncol,2019

2. Cancer statistics in China, 2015.;Chen;CA Cancer J Clin,2016

3. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer.;Tveit;Br J Surg,1997

4. Effective surgical adjuvant therapy for high-risk rectal carcinoma.;Krook;N Engl J Med,1991

5. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.;Gérard;J Clin Oncol,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of intensity‐modulated radiotherapy in conjunction with chemotherapy on proximal pT3N0 rectal cancer patients after total mesorectum excision;Cancer Medicine;2023-11-06

2. Adjuvant chemotherapy does not improve cancer-specific survival for pathologic stage II/III rectal adenocarcinoma after neoadjuvant chemoradiotherapy and surgery: evidence based on long-term survival analysis from SEER data;International Journal of Colorectal Disease;2023-05-18